Science Explorer Interactive view Map
Topic · Immunology

Biomarkers in Disease Mechanisms

Biomarkers in Disease Mechanisms is a research topic within Immunology. Science Explorer counts 12k research works in it since 1950. 12.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the role of pentraxins, particularly PTX3, in innate immunity, inflammation, cardiovascular diseases, tissue remodeling, infection, autoimmunity, and cancer. The research covers various aspects of pentraxin function, including pattern recognition, interaction with complement system, biomarker potential, and therapeutic implications.

  • Pentraxins
  • Innate Immunity
  • Inflammation
  • Pattern Recognition
  • PTX3
  • Cardiovascular Disease
  • Tissue Remodeling
  • Infection
  • Autoimmunity
  • Cancer
Research works
12k
fractional, since 1950
In the world top 10%
1.5k
per year above
Top-10% rate
12.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+52%
the tick is no change

Which countries lead Biomarkers in Disease Mechanisms research?

By volume, China and the United States publish the most (876 and 308 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 876 works
  2. 2 United States 308 works
  3. 3 India 184 works
  4. 4 Russia 181 works
  5. 5 Türkiye 137 works
  6. 6 Iraq 128 works
  7. 7 Egypt 93 works
  8. 8 Ukraine 88 works
  9. 9 Italy 81 works
  10. 10 Iran 78 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 40.7%United States: 14.3%India: 8.5%Russia: 8.4%6 others listed: 28.1%41%largest
China876 · 40.7%United States308 · 14.3%India184 · 8.5%Russia181 · 8.4%6 others listed605 · 28.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Biomarkers in Disease Mechanisms research?

By volume in 2022–2025, University of Baghdad publishes the most Biomarkers in Disease Mechanisms research, followed by Ain Shams University and Capital Medical University.

By volume, 2022–2025

  1. 1 University of BaghdadIraq 21 works
  2. 2 Ain Shams UniversityEgypt 16 works
  3. 3 Capital Medical UniversityChina 15 works
  4. 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
  5. 5 Sağlık Bilimleri ÜniversitesiTürkiye 14 works
  6. 6 Sun Yat-sen UniversityChina 11 works
  7. 7 University of KufaIraq 11 works
  8. 8 Sechenov UniversityRussia 9 works
  9. 9 Central South UniversityChina 9 works
  10. 10 Tanta UniversityEgypt 8 works

Where is Biomarkers in Disease Mechanisms research done?

The largest centres of Biomarkers in Disease Mechanisms research in 2022–2025 are Beijing (China), Moscow (Russia), Guangzhou (China) and Shanghai (China).

Largest cities, 2022–2025

  1. 1 Beijing China 99 works
  2. 2 Moscow Russia 62 works
  3. 3 Guangzhou China 61 works
  4. 4 Shanghai China 51 works
  5. 5 Baghdad Iraq 42 works
  6. 6 Istanbul Türkiye 34 works
  7. 7 Hangzhou China 31 works
  8. 8 Nanjing China 30 works
  9. 9 Wuhan China 29 works
  10. 10 Tehran Iran 28 works
See Biomarkers in Disease Mechanisms on the map

Where is the best place to study Biomarkers in Disease Mechanisms?

Among universities, judged by research, Capital Medical University, University of Baghdad and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 11.27%fractional works in this node (log) →share in the world top 10% →Capital Medical University: 15, 19.7%University of Baghdad: 21, 0.0%Chinese Academy of Medical Sciences & Peking Union Medical College: 14, 17.8%Ain Shams University: 16, 0.0%Sağlık Bilimleri Üniversitesi: 14, 4.1%Fujian Medical University: 8, 23.6%Medical University of Silesia: 8, 14.5%Tanta University: 8, 0.0%Sechenov University: 9, 4.6%Sun Yat-sen University: 11, 28.4%Capital Medical Univ…Chinese Academy of M…University of BaghdadAin Shams University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Capital Medical UniversityChina 58.519.7%8.7×15 +80.6%
2 University of BaghdadIraq 57.70.0%9.7×21 +180.7%
3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 52.617.8%4.9×14 +176.4%
4 Ain Shams UniversityEgypt 50.00.0%7.3×16 +202.5%
5 Sağlık Bilimleri ÜniversitesiTürkiye 48.94.1%8.1×14 —
6 Fujian Medical UniversityChina 45.023.6%7.7×8 +90.1%
7 Medical University of SilesiaPoland 44.214.5%15.1×8 +69.3%
8 Tanta UniversityEgypt 42.80.0%9.0×8 +136.4%
9 Sechenov UniversityRussia 42.44.6%9.6×9 —
10 Sun Yat-sen UniversityChina 39.128.4%2.4×11 +27.6%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Biomarkers in Disease Mechanisms research growing?

Output in 2018–2022 was 52% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Biomarkers in Disease Mechanisms.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.